Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients
NCT ID: NCT05801757
Last Updated: 2024-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2023-05-01
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy
NCT05255211
Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy
NCT03779061
The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps
NCT04906317
Sedation Techniques for Outpatient Colonoscopy
NCT04686058
Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy
NCT01693185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol group
propofol 2-3mg/kg/h
Propofol
propofol 2-3mg/kg/h
R1 group
remimazolam 0.5mg/kg/h
Remimazolam
Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect
R2 group
remimazolam 0.75mg/kg/h
Remimazolam
Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remimazolam
Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect
Propofol
propofol 2-3mg/kg/h
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA Level I - III;
* Operation time: 15min\~1h;
* BMI18.0-29.9；
Exclusion Criteria
* Patients with high risk of gastric satiety and reflux aspiration;
* Allergies to benzodiazepines and opioids;
* Those who have taken sedative, analgesic, or antidepressant drugs within 24 hours;
* Abnormal liver and kidney function;
* Previous drug use history;
* Recently participated in other clinical studies;
* Patients who cannot cooperate with communication.
60 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
aijun xu
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
aihua Du, Dr.
Role: STUDY_CHAIR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongji Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.